stearoyl alpha-lysolecithin has been researched along with Endotoxemia in 1 studies
*Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billiar, TR; Deng, M; Li, W; Liao, H; Liu, J; Loughran, P; Lu, B; Tang, Y; Zhang, W; Zhang, X | 1 |
1 other study(ies) available for stearoyl alpha-lysolecithin and Endotoxemia
| Article | Year |
|---|---|
Stearoyl Lysophosphatidylcholine Inhibits Endotoxin-Induced Caspase-11 Activation.
Topics: Animals; Caspases; Caspases, Initiator; Endotoxemia; Enzyme Activation; Interleukin-1alpha; Interleukin-1beta; Lipopolysaccharides; Lysophosphatidylcholines; Macrophages, Peritoneal; Mice | 2018 |